Work

Radioligandentherapie mit 177Lu-PSMA-617 (Pluvicto): Klinische Erfahrungen nach der Zulassung

Year: 2026

Type: article

Study design: Observational Study

Source: Nuklearmedizin - NuclearMedicine

DOI: 10.1055/s-0046-1818378

Authors: C Probst, N Hasenauer, T Jedamzik, A Buck, A K Seitz, P Hartrampf

Institution: Universitätsklinikum Würzburg

Language: German

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148276807

FWCI:

Cites:

Cited by:

Related to: 10